European countries have stopped the vaccination roll-out of AstraZeneca’s COVID-19 vaccine.

The AstraZeneca vaccine has been put on hold in Europe and other countries. Germany is the latest country to halt the use of AstraZeneca’s vaccine.

The Problem A few dozen people have developed blood clots out of over 17 million people vaccinated. AstraZeneca claims that these numbers are well within the safe range. Additionally, the company claims that other vaccine manufacturers have similar clotting issues.

Germany The United States, Israel, and the United Kingdom are leading the world in the number of vaccinations per 100 people. Israel is average over 100 vaccinations per 100 people.

Sweden and Portugal stopped the distribution of AstraZeneca this week after France, Italy, and Germany halted the vaccine’s use. European countries are demanding an investigation by the European Medicines Agency (EMA) into the blood clot problem.

Germany’s vaccination program was hoping to stave off a potential third wave of new COVID-19 cases. New cases declined to low levels in February and are incrementally increasing. As the weather improves around Easter, speculators tell the German citizens to prepare for the next upsurge in coronavirus.

The Start of Stopping Denmark, Iceland, and Norway were the first to stop using AstraZeneca’s vaccine last week. Even though AstraZeneca claims there is no link between their vaccine and the side effects being seen.

The company maintains that the safety data from over 10 million people show no safety concerns, especially with pulmonary health concerns. The United Kingdom pharmaceuticals regulator is standing behind AstraZeneca and not stopping any further vaccine distribution in England. Britain has seen a 94% drop in hospitalizations since the vaccine was rolled out.

The United States and AstraZeneca AstraZeneca has not applied for Emergency Use Authorization (EUA) in the United States. The United States Phase III independent monitors are currently reviewing clinical trials. Final approval will not happen before Easter, and it may take two to four weeks after Easter to receive the EUA.

Countries south of the United States had hoped to receive the AstraZeneca vaccine by now. Production problems are creating vaccine shortages. Mexico is considering the Chinese or Russian vaccine to replace the AstraZeneca vaccine.

The United States has around 30 million AstraZeneca vaccine doses stored awaiting approval. Along with 70 other countries, Mexico has approved the vaccine for domestic use and has asked to borrow from the American stockpile.


Is there a problem with blood clotting and AstraZeneca’s vaccine? The company claims there is not, but fear is a hard thing to control. A little pinch of panic added to anxiety and apprehension can shut down a program in a heartbeat beat, as we have seen with the decisions to halt the vaccine.

The virus has a 99% survivability rate for most of us. The vaccine prevents people from hospitalizations and deaths. Is politics alive and well? Is there a different engineer driving the train? Something does not smell right.

People currently receiving vaccines are monitored for at least 30 minutes to ensure no severe side effects. The people I know who have been vaccinated tell me that the first shot had nothing to write home about, and the second one left them with a sore shoulder and a bit fatigued for a day or two.

Is it possible to extend the 30-minute monitoring time after being vaccinated to an hour or longer? Are there certain traits of the 40 or so people who have experienced blood clots – obesity, hypertension, over 70 years of age, or something else that identifies who is most significant at risk for clotting?

When do you raise the flag and say, NO MORE? Forty people out of ten million may be a concern? What about nearly a thousand deaths from the other two vaccine manufacturers out of 65 million vaccinations?

Live Longer & Enjoy Life! – Red O’Laughlin –


2 Responses

Leave a Reply

Your email address will not be published. Required fields are marked *